News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
89,651 Results
Type
Article (6606)
Company Profile (37)
Press Release (83008)
Section
Business (27711)
Career Advice (129)
Deals (3991)
Drug Delivery (29)
Drug Development (14054)
Employer Resources (12)
FDA (2804)
Job Trends (2113)
News (49064)
Policy (5991)
Tag
Academia (423)
Africa (91)
Alabama (11)
Allergies (17)
Alliances (8930)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (17)
Approvals (2788)
Artificial intelligence (12)
Asia (7229)
Australia (856)
Bankruptcy (17)
Best Places to Work (1722)
Biosimilars (42)
Biotechnology (25)
C2C Services and Suppliers (6438)
California (348)
Canada (104)
Cancer (87)
Career advice (111)
Cell therapy (29)
China (45)
Clinical research (10928)
Collaboration (29)
Colorado (11)
Complete response letters (9)
COVID-19 (519)
Cystic fibrosis (12)
Data (42)
Diabetes (10)
Diagnostics (486)
Drug pricing (14)
Earnings (9031)
Employer resources (10)
Europe (13367)
Events (11245)
Executive appointments (18)
FDA (2869)
Florida (36)
Funding (14)
Gene therapy (27)
GLP-1 (86)
Government (1280)
Healthcare (1943)
Hotbed/Location (58965)
Idaho (13)
Illinois (18)
Indiana (17)
Infectious disease (522)
Inflammatory bowel disease (34)
Interviews (10)
IPO (1821)
Job creations (387)
Job search strategy (109)
Layoffs (44)
Legal (552)
Liver cancer (10)
Lung cancer (31)
Manufacturing (31)
Maryland (166)
Massachusetts (223)
Medical device (1154)
Medtech (1155)
Mergers & acquisitions (2173)
Metabolic disorders (24)
Minnesota (29)
Neuroscience (235)
New Jersey (186)
New York (90)
NextGen Class of 2024 (693)
Non-profit (349)
North Carolina (122)
Northern California (158)
Obesity (10)
Ohio (21)
Opinion (38)
Peanut (16)
Pennsylvania (80)
People (7758)
Phase I (3569)
Phase II (4563)
Phase III (4009)
Pipeline (33)
Policy (19)
Postmarket research (293)
Preclinical (1397)
Press Release (66)
Rare diseases (21)
Real estate (912)
Regulatory (4465)
Reports (10)
Research institute (385)
Resumes & cover letters (13)
South America (133)
Southern California (159)
Startups (572)
Texas (25)
United States (1475)
Vaccines (114)
Washington State (29)
Date
Today (1)
Last 7 days (101)
Last 30 days (365)
Last 365 days (6910)
2024 (4660)
2023 (6983)
2022 (9103)
2021 (9534)
2020 (8227)
2019 (5875)
2018 (4539)
2017 (5064)
2016 (4628)
2015 (5280)
2014 (3732)
2013 (2904)
2012 (2995)
2011 (3158)
2010 (2580)
89,651 Results for "rucdr infinite biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biologics Market Size to Reach USD 699.5 Billion by 2032, Impelled by Emergence of Advanced Drug Delivery Systems
Biologics Market Outlook 2024-2032:
August 8, 2024
·
14 min read
China
WuXi Biologics Takes Net Profit Hit Despite Inking Record Number of New Projects
With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.
August 22, 2024
·
2 min read
·
Tristan Manalac
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Policy
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates
GenSight Biologics announced the renegotiation of certain financial obligations, securing its financial position and improving short-term flexibility.
June 20, 2024
·
6 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Pharm Country
RUCDR Infinite Biologics Becomes Infinity BiologiX
Company spins off from Rutgers University to strengthen its impact and leadership position as a Next-Generation Central Laboratory
August 19, 2020
·
5 min read
Policy
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”), is pleased to announce the results of its 2024 annual meeting of shareholders (the “Meeting”) held on June 27, 2024.
June 28, 2024
·
4 min read
BioForest
Biolog Delves Into Characterizing Gut Microbiomes With the Launch of PreBioM Plates
Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products and services, is excited to announce the launch of its new PreBioM™ microplate product line for microbiome analysis and organism selection.
June 11, 2024
·
2 min read
Business
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB) today reported financial results and recent business highlights for its first quarter ended March 31, 2024.
May 15, 2024
·
13 min read
Pharm Country
Studies Show Linked Biological Pathways Driving Skin Inflammation
A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds.
May 20, 2024
·
6 min read
1 of 8,966
Next
